Thursday 28 April 2022

AstraZeneca's Evusheld slashes risk of symptomatic COVID-19 up to 83%

AstraZeneca's Evusheld slashes risk of symptomatic COVID-19 up to 83% submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/TqmL6oC
via IFTTT

No comments:

Post a Comment